- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A Case Report of Advanced Male Breast Cancer with Lung Metastasis Treated with Endocrine Therapy Combined with Palbociclib
-
- OKI Toyokazu
- Breast Center, Kochi Medical School Hospital Department of Surgery, Kochi Medical School
-
- SUGIMOTO Takeki
- Breast Center, Kochi Medical School Hospital Department of Surgery, Kochi Medical School
-
- ISHIDA Nobuko
- Breast Center, Kochi Medical School Hospital Department of Surgery, Kochi Medical School
-
- FUKUNAGA Yukiko
- Breast Center, Kochi Medical School Hospital Department of Surgery, Kochi Medical School
-
- DABANAKA Ken
- Department of Surgery, Seiwa Hospital
-
- SEO Satoru
- Department of Surgery, Kochi Medical School
Bibliographic Information
- Other Title
-
- Palbociclib併用内分泌療法を行った進行男性乳癌の1例
- Palbociclib ヘイヨウ ナイブンピ リョウホウ オ オコナッタ シンコウ ダンセイ ニュウガン ノ 1レイ
Search this article
Description
<p>Tamoxifen is firstly recommended for hormone positive advanced male breast cancers. On the other hand, CDK 4/6 inhibitors are mainly used together with endocrine therapy for hormone positive advanced breast cancers. We report a case of advanced male breast cancer treated with aromatase inhibitor combined with CDK 4/6 inhibitor. A 72-year-old man presented with a right thoracic mass with self-destruct and bleeding. Respiratory distress and anemia (Hb ; 5.0 g/dl) were noted, and blood tests showed elevated tumor markers. The pathological examination showed invasive ductal carcinoma (tubule forming) with positive for ER and PgR, negative for HER2, and 40 % for MIB-1 labeling index. There were multi-organ metastasis (lung, bone, and lymph nodes) on PET-CT scan and duodenal benign ulcer with upper gastrointestinal endoscopy. Chemotherapy was avoided because of his risk for ulcer perforation, serious anemia and decreased pulmonary function. Therefore, an endocrine regimen with Letrozole plus Palbociclib was started and produced a good response. This treatment is expected to be effective for male as well as female breast cancers in hormone-positive patients.</p>
Journal
-
- Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
-
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 85 (1), 9-14, 2024
Japan Surgical Association
